People with the rarest type of ANCA-associated vasculitis (AAV), called eosinophilic granulomatosis with polyangiitis (EGPA), and AAV patients with reduced kidney function are more likely to experience thrombosis (blood clots that disrupt blood flow), according to a single-center study in China. Results also indicated AAV patients with higher…
Summer promises good weather, high spirits, and easy travel. There’s nothing like an old-fashioned road trip to capture the excitement and freedom of exploration. Though there might be a thunderstorm here and there, it’s tempting to get on the road and stay there till fall. For those of us with…
People with ANCA-associated vasculitis (AAV) are at a greater risk of venous thromboembolism — blood clots in veins — if they have evidence of bleeding into the lungs, heart involvement, red blood cells in their urine, or anti-PR3-ANCA autoantibodies, according to a study in patients of a Phase…
Patients with ANCA-associated vasculitis (AAV) who have persistent antiphospholipid antibodies (APLAs) at diagnosis are at a greater risk of developing blood clots, with consequent obstruction of the blood flow, according to new research. The study, “Persistent antiphospholipid antibodies are associated with thrombotic events in ANCA-associated vasculitis: A retrospective…
Get regular updates to your inbox.